Welcome to our dedicated page for IDEX news (Ticker: IEX), a resource for investors and traders seeking the latest updates and insights on IDEX stock.
IDEX Corporation (NYSE: IEX) is a global engineered products company serving critical industrial, health and science, and fire and safety markets. This news page aggregates company announcements, earnings releases and other corporate updates so readers can follow how IDEX executes its strategy across its three primary segments: Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety / Diversified Products.
Visitors can review quarterly and annual financial results, where IDEX discusses segment performance, organic sales trends, acquisitions and platform optimization efforts. Earnings releases often highlight factors such as pricing, volume changes in end markets like life sciences, pharmaceuticals, aerospace and defense, semiconductors, water and fire and safety, as well as the impact of acquisitions including Mott Corporation and Micro-LAM, Inc.
The news feed also includes information on capital allocation decisions, such as regular quarterly cash dividend declarations and share repurchase authorizations, along with commentary on the company’s balanced deployment of free cash flow. Corporate governance and leadership updates, including appointments of senior executives, are disclosed through press releases and related Form 8-K filings and appear in this stream.
For investors tracking IEX stock, this page provides a centralized view of IDEX’s public communications, from webcast announcements for earnings calls to updates on its 8020 operating approach and growth platforms. Bookmark this page to access a chronological record of IDEX Corporation news and to monitor how management describes the company’s performance, portfolio evolution and role in critical industries over time.
IDEX (NYSE: IEX) reported record 2025 sales of $3.46B, up 6% reported and 1% organic, and record Q4 sales of $899.1M, up 4% reported and 1% organic. Full-year adjusted diluted EPS was $7.95, up 1%; reported diluted EPS was $6.41, down 3%.
Q4 orders were a record $979.2M, up 20% reported and 16% organically. Operating cash flow was $680M and free cash flow $617M. The company repurchased $248M of shares during 2025 and expects 2026 adjusted diluted EPS of $8.15–$8.35 and organic sales +1% to +2%.
IDEX Corporation (NYSE:IEX) will release its fourth quarter 2026 results on Wednesday, February 4, 2026 prior to market open. An investor conference call and webcast with CEO Eric Ashleman and SVP & CFO Sean Gillen will begin at 8:00 a.m. CT the same day.
The live webcast and earnings presentation will be available in listen-only mode on the company's Investor Relations site. Telephone access is available at 888-596-4144 with confirmation code 2518354; participants are asked to dial in five minutes early. A replay of the call will be available via webcast on the company website.
IDEX Corporation (NYSE:IEX) announced that Sean M. Gillen will join as Senior Vice President and Chief Financial Officer, effective January 5, 2026. Mr. Gillen joins after nearly seven years as CFO of AAR CORP and previously held senior finance roles at USG and Goldman Sachs. Akhil Mahendra will return to Vice President, Corporate Development after serving as interim CFO since May 2025. The company also announced that Melissa S. Flores, Senior Vice President and Chief Human Resources Officer, will depart effective December 19, 2025, and IDEX intends to hire an external CHRO while leveraging existing leaders to manage HR operations.
IDEX Corporation (NYSE:IEX) announced a regular quarterly cash dividend of $0.71 per common share.
The dividend will be paid on January 30, 2026 to shareholders of record as of January 16, 2026. This payment marks the company's 125th consecutive regular quarterly cash dividend.
IDEX (NYSE: IEX) reported record Q3 2025 results: $879M sales (+10% reported, +5% organic), record orders of $880M (+13% reported, +7% organic) and adjusted diluted EPS of $2.03 (up 7%). GAAP diluted EPS was $1.70. Free cash flow was $188.7M and management expects at least 100% free cash flow conversion for FY2025. The company narrowed full‑year guidance to GAAP EPS $6.35–$6.40 and adjusted EPS $7.86–$7.91. IDEX repurchased $75M of shares in Q3 and increased its buyback authorization to $1B. Results reflect the impact of the Mott acquisition and platform optimization savings.
IDEX Corporation (NYSE:IEX) will release third quarter 2025 results on Wednesday, October 29, 2025, prior to market open. An investor conference call and webcast with CEO Eric Ashleman and VP Corporate Development & Interim CFO Akhil Mahendra is scheduled for 8:00 a.m. CT the same day.
The event and earnings presentation will be available in listen-only mode via the company's Investor Relations site at https://investors.idexcorp.com/events. Telephone participation is available at (877) 709-8150 or (201) 689-8354 using confirmation code 13748413. A replay will be accessible via webcast on the company's website.
IDEX Corporation (NYSE:IEX) has announced a significant expansion of its share repurchase program, increasing the total authorization to $1 billion from the previous $440 million remaining as of June 30, 2025. The company has already demonstrated its commitment to shareholder returns by repurchasing over $100 million in shares during the first half of 2025.
Additionally, IDEX declared its 124th consecutive quarterly dividend of $0.71 per share, payable on October 24, 2025, to shareholders of record as of October 10, 2025. The company expects to return at least 70% of free cash flow to shareholders through dividends and share repurchases in 2025, while maintaining focus on bolt-on acquisitions and implementing its 8020 operating model.
IDEX Corporation (NYSE: IEX) reported Q2 2025 results with record sales of $865 million, up 7% overall and 1% organically. The company reported diluted EPS of $1.74 (down 6%) and adjusted EPS of $2.07 (flat year-over-year). Orders reached $830 million, increasing 7% on a reported basis and 2% organically.
Due to challenging market conditions and cautious customer behavior, IDEX revised its full-year guidance downward to GAAP EPS of $6.30-$6.44 (previously $6.56-$6.95) and adjusted EPS of $7.85-$7.95 (previously $8.10-$8.45). For Q3 2025, the company expects GAAP EPS of $1.54-$1.61 and adjusted EPS of $1.90-$1.95.
Notable events include the acquisition of Micro-LAM for $90 million plus potential earnout, repurchase of 268,586 shares for $50 million, and repayment of $100 million in Senior Notes.
IDEX Corporation (NYSE:IEX) has scheduled its second quarter 2025 earnings release for July 30, 2025, before market open. The company will host an investor conference call at 8:00 a.m. CT featuring CEO Eric Ashleman and Interim CFO Akhil Mahendra.
IDEX, founded in 1988, is a global engineering company with $3.3 billion in annual sales, operating across more than 50 businesses worldwide. The company employs approximately 9,000 people with manufacturing operations in over 20 countries, specializing in engineered products and mission-critical components for various industries including electronics, water treatment, healthcare, and emergency response.